How Does an Egg Choose? What Fertilization Science Means for Your IVF Care
Medically Reviewed by Dr. Silvana Chedid on October 21, 2026

For a long time, fertilization was described as a race, with millions of sperm charging toward a passive egg waiting to be won. Research now points to a different story. The egg plays an active role, releasing chemical signals that help guide which sperm are drawn toward it. This discovery changes how scientists and patients see the very first moment of life, and it offers a helpful lens for anyone weighing assisted reproduction options.
At Chedid Grieco, we have spent 28 years advancing fertility care, including in vitro fertilization, for individuals and couples from around the world. Our reproductive medicine clinic offers consultations in Miami and treatments at our state-of-the-art laboratory in São Paulo, Brazil. We stay current with emerging science so we can build personalized, boutique treatment plans around each patient’s needs.
What the Research Says About Egg Biology
A 2020 study published in Proceedings of the Royal Society B came from researchers affiliated with Stockholm University and Manchester University NHS Foundation Trust. The team examined how sperm respond to follicular fluid, the liquid that surrounds a mature egg and carries chemical signals called chemoattractants. In the experiments, follicular fluid from one woman attracted sperm from one man better than sperm from another, which suggests these interactions depend on the specific people involved.
The researchers noted this type of communication between eggs and sperm may let eggs bias which sperm ultimately fertilizes them, a mechanism scientists call cryptic female choice. Fertilization, in other words, looks closer to a two-way exchange than a purely mechanical event, and the egg appears to have a say in the process.
How Egg Signaling Fits Into the Bigger Picture
Reaching the egg is already a remarkable feat, because sperm must clear several hurdles first:
- Vaginal acidity: Sperm must survive an acidic environment from the start.
- Cervical mucus: Only some sperm make it through this natural barrier.
- Fallopian tube: Sperm must travel the full length of the tube to reach the egg.
- Outer protective layers: Sperm must get past the egg’s outer barriers before fertilization can occur.
Only a small number of sperm typically reach the site of fertilization, and the egg’s chemical environment may help shape which of them are ultimately involved in the process.
What This Means for Fertility Treatment
This science is relevant to patients exploring assisted reproduction, though it plays out differently depending on the technique used. In conventional IVF, multiple sperm are placed near the egg in a laboratory setting, so some of this natural chemical environment may still be present. With intracytoplasmic sperm injection, where a single sperm is placed directly into the egg, this step is bypassed by design. That is one reason lab precision and embryology experience matter so much in that setting.
Research like this also reinforces something we see in our own patients every day. No two fertility paths look alike, and every patient deserves a plan built around the individual biology involved, not a one-size-fits-all protocol. Researchers are still learning how these findings translate into clinical care, so this science is best seen as helpful context rather than a way to predict results for any one person.
A New Option Without Ovarian Stimulation
For patients who want to reduce the physical burden of a traditional IVF cycle, we now offer in vitro maturation, a technique Dr. Chedid brought back after a recent trip to Vietnam. It allows us to retrieve eggs without the injectable ovarian stimulation medications used in traditional IVF or egg freezing, eliminating the 10- to 12-day injection period many patients find uncomfortable.
Instead, the eggs are matured in the lab rather than with medication, which can make the process gentler for many patients. This is one more example of how fertility science keeps evolving, and why staying current matters for the families we serve. It also reflects our broader focus: helping patients build families through IVF, egg donation, and egg preservation, rather than treating any single piece of the process in isolation.
Personalized Fertility Care at Chedid Grieco
At Chedid Grieco, we believe every path to parenthood deserves a plan built around your unique biology. Our clinic is 1 of only 8 outside the United States to hold a New York Tissue License, and we bring 28 years of experience and 8,780 babies born to every patient relationship. We are a female-led clinic that is FDA-licensed and NYDH-licensed, and we are proud supporters of LGBTQI+ families who welcome individuals of all backgrounds.
With 1,200 cycles per year and 8 doctors working for you, our team is ready to help. Consultations are available in Miami, with treatments conducted at our laboratory in São Paulo, Brazil. To learn more about traveling for care, reach out through our contact form to start building your personalized treatment plan.
About the Author
Reproductive Medicine Physician, Chedid Grieco
Dr. Silvana Chedid has practiced reproductive medicine for more than 25 years and introduced Intracytoplasmic Sperm Injection (ICSI) to Brazil. She leads the clinical team at Chedid Grieco, which holds consultations in Miami and provides treatment at an FDA- and NYDH-licensed facility in Sao Paulo, Brazil.
